查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1888583

全球潜伏性结核感染检测市场：市场规模、份额、趋势分析（按品牌、检测方法、应用、最终用途和地区划分）、细分市场预测（2025-2033 年）

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test (TST, IGRA), By Application, By End Use (Diagnostic Laboratories, Hospitals/Clinics), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

LTBI检测市场概览

2024年全球LTBI检测市场规模估计为19.1亿美元，预计2033年将达31.6亿美元。

预计从 2025 年到 2033 年，该市场将以 5.81% 的复合年增长率成长。市场成长归因于患有活动性结核病的风险增加以及人们对结核病早期诊断意识的提高。

此外，政府持续主导的对抗结核病威胁的努力以及新型诊断方案的日益普及，预计将推动潜伏性结核感染（LTBI）检测市场的成长。 LTBI 患者终生面临重新运作的风险，估计约为 5% 至 15%，其中大多数患者会在五年内发展为结核病。在拥有者中，未经治疗的 HIV 感染和 LTBI 治疗失败是高风险因素，年死亡率约为 7% 至 10%，凸显了及时介入的重要性。此外，美国大多数结核病病例是由两年前感染的 LTBI 进展引起的，这凸显了控制 LTBI 以预防未来病例的关键性。

增加结核病诊断计画的资金投入对于对抗这一全球性疾病至关重要。目前用于预防、诊断和治疗的资金不足以满足需求，阻碍了降低发病率和死亡率的进展。例如，儘管已设定到2027年每年投资220亿美元的目标，并额外拨款50亿美元用于研究，但仅有58亿美元被分配给结核病控制服务，远低于实现全球目标所需的金额。世界卫生组织进一步强调，需要持续增加资金投入才能有效消除结核病。

为因应这项挑战，美国政府大幅增加了结核病防治资金，从2013年的2.33亿美元增加到2023年的4.06亿美元。筛检和预防性治疗的投资具有显着的健康和经济效益，投资报酬率高达每投入1美元可获得39美元的回报。因此，扩大对结核病诊断计画的投资，以改善诊断、治疗和预防服务的可近性，对于在2033年前消除结核病流行至关重要。此外，全球基金提供了结核病防治国际总资金的76%，已拨款92亿美元用于预防和治疗项目，併计划在2023年6月前额外拨款15亿美元用于结核病/爱滋病毒项目。在2002年至2022年间，接受全球基金支持的国家结核病相关死亡人数下降了36%。

此外，全球老年人口的不断增长对该年龄层的结核病控制构成重大挑战。老年人群的结核病病例发现率和发病率尤其高，凸显了在结核病控制策略中纳入针对老年人群的特定措施以应对其日益增长的风险的重要性。在人口老化迅速的西太平洋地区，老年族群的结核病病例显着增加，迫切需要针对这群脆弱者制定个人化的诊断、治疗和照护方案。这将推动开发高效且便捷的诊断方法，以满足日益增长的老年人管理需求。

然而，监管核准法律规范对製药、生技和医疗科技产业的成长速度构成了重大限制。在全球范围内，诊断测试的使用和安全性因国家而异，且各国卫生监管机构的评估方式也各不相同，这往往会延缓新产品的核准。

目录

第一章 潜伏性结核感染检测市场：分析方法与范围

2. 潜伏性结核感染检测市场：执行摘要

  • 市场概览
  • 品牌概览
  • 测试概述
  • 最终用途概述
  • 应用概述
  • 竞争格局概述

3. LTBI检测市场：影响因素、趋势与范围

  • 市场区隔/范围
  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 潜伏性结核感染（LTBI）发展为活动性结核感染疾病的风险增加
    • 增加资金支持项目，以促进结核病诊断
    • 政府积极主动防治结核病
    • 老年人口快速成长
  • 市场限制因素分析
    • 严格的诊断规章制度
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 LTBI检测市场：按品牌分類的估算与趋势分析

  • 全球潜伏性结核感染检测市场：品牌概览
  • 全球潜伏性结核感染检测市场：品牌波动分析
  • 全球LTBI检测市场（按收入和品牌划分）
  • QFT-Plus（Quantiferon-TB Gold Plus）
  • 其他的

第五章 潜伏性结核感染检测市场：依检测方法分類的估算与趋势分析

  • 全球潜伏性结核感染检测市场（依检测方法划分）概览
  • 全球潜伏性结核感染检测市场：依检测方法分類的波动分析
  • 全球潜伏性结核感染检测市场（按收入和检测方法划分）
  • 结核菌素皮肤试验（TST）
  • 干扰素-γ释放试验（IGRA）

第六章：LTBI检测市场：按应用分類的估算与趋势分析

  • 全球潜伏性结核感染检测市场：按应用分類的概览
  • 全球潜伏性结核感染检测市场：波动分析（按应用领域划分）
  • 全球LTBI检测市场（按收入和应用划分）
  • 肺结核患者的家庭接触者
  • 爱滋病毒感染者
  • 其他的

7. LTBI检测市场：依最终用途分類的估算与趋势分析

  • 全球潜伏性结核感染检测市场：依最终用途分類的概览
  • 全球潜伏性结核感染检测市场：依最终用途分類的差异分析
  • 全球LTBI检测市场按收入和最终用途划分
  • 诊断检查室
  • 医院和诊所
  • 学术和研究机构

8. LTBI检测市场：区域估算和趋势分析（按产品类型、技术和最终用途划分）

  • 区域仪錶板
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
    • 荷兰
    • 比利时
    • 芬兰
    • 卢森堡
    • 冰岛
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 新加坡
    • 孟加拉
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 主要市场参与企业的最新趋势及影响分析
  • 公司/竞争格局分类
  • 供应商概况
    • 主要经销商和通路合作伙伴名单
    • 主要客户
    • 主要企业市占率分析（2023）
    • QIAGEN
    • BIOMERIEUX
    • Oxford Immunotec
    • SD Biosensor, INC.
    • Wantai BioPharm
    • Lionex GmbH
    • Sanofi
    • Serum Institute of India Pvt. Ltd
    • ARKRAY, Inc.
    • Par Pharmaceutical, Inc.
Product Code: GVR-4-68039-994-9

Latent Tuberculosis Infection Detection Market Summary

The global latent tuberculosis infection detection market size was estimated at USD 1.91 billion in 2024, and is projected to reach USD 3.16 billion by 2033, growing at a CAGR of 5.81% from 2025 to 2033. The growth of the market is attributed to the increasing risk of developing active tuberculosis and the growing awareness among people to diagnose tuberculosis infection at an early stage.

Moreover, ongoing government initiatives to combat the threat of tuberculosis and the increasing introduction of novel diagnostic solutions are anticipated to fuel the latent tuberculosis infection (LTBI) detection market growth. Individuals with LTBI face a lifetime risk of reactivation, which is expected to be around 5% to 15%, with the majority of the population developing TB within the first 5 years. For those with LTBI, untreated HIV infection and no LTBI treatment can lead to a high risk of about 7%-10% per year, emphasizing the importance of timely intervention. In addition, most TB cases in the U.S. result from the progression of LTBI acquired over 2 years ago, highlighting the significance of addressing LTBI to prevent future cases.

The increasing funding for TB diagnosis programs is crucial in the fight against this global disease. The current funding for prevention, diagnosis, and treatment is insufficient to meet the demand, hindering progress in reducing incidence & mortality rates. For instance, an annual investment of USD 22 billion by 2027 was set, with an additional USD 5 billion for research, and only USD 5.8 billion was allocated for TB services, falling short of the required amounts to achieve global targets. Moreover, WHO emphasizes the need for sustained & increased funding to combat TB effectively.

Hence, the U.S. government has significantly increased its funding for TB initiatives, from USD 233 million in 2013 to USD 406 million in 2023. Investments in screening and preventive treatment have shown significant health & economic benefits, with a return on investment of up to USD 39 for every dollar spent. Hence, expanding investments in TB diagnosis programs is essential to improve access to diagnosis, treatment, and prevention to eliminate the TB epidemic by 2033. Moreover, the Global Fund contributes 76% of total international funding for TB, having allocated USD 9.2 billion toward prevention & treatment programs and an extra USD 1.5 billion for TB/HIV initiatives by June 2023. In countries receiving support from the Global Fund, TB-related fatalities have decreased by 36% from 2002 to 2022.

Moreover, the increasing number of elderly individuals worldwide poses a major hurdle in the control of TB within this age group. The rates of TB case detection & incidence are particularly high among older adults, emphasizing the importance of incorporating specific measures in TB response strategies to address their increased risk. In the Western Pacific, where the population is aging rapidly, there has been a notable increase in TB cases among older individuals, propelling the need for customized approaches to diagnosis, treatment, and care for this vulnerable demographic. This is expected to improve the need for the development of effective & efficient diagnostics to meet the rising demand for management among older populations.

However, the regulatory framework for approvals poses major restraints on the growth rate of the pharmaceutical, biotechnology, and medical technology industries. Globally, usage & safety profiles of diagnostic tests vary and are evaluated by health regulatory agencies of each country differently. This makes the approval of novel products slower.

Global Latent Tuberculosis Infection Detection Market Report Segmentation

This report forecasts revenue & volume growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the latent tuberculosis infection detection market report based on brand, test, application, end use, and region:

  • Brand Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021 - 2033)
  • QFT-Plus (QuantiFERON-TB Gold Plus)
  • Others
  • Test Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021 - 2033)
  • Tuberculin Skin Test (TST)
  • Interferon Gamma Released Assay (IGRA)
  • Application Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021 - 2033)
  • Household Contacts with Pulmonary TB
  • PLHIV
  • Others
  • End Use Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021 - 2033)
  • Diagnostic Laboratories
  • Hospitals/Clinics
  • Academic & Research Institutions
  • Regional Outlook (Volume, Thousand Tests; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Belgium
    • Finland
    • Luxembourg
    • Iceland
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Bangladesh
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Latent Tuberculosis Infection Detection Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Test Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Latent Tuberculosis Infection Detection Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Brand Snapshot
  • 2.3. Test Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Application Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increasing risk of developing active tuberculosis infection from LTBI
    • 3.4.2. Increasing funding programs to promote TB diagnosis
    • 3.4.3. Favorable government initiatives for combating TB
    • 3.4.4. Surge in geriatric population
  • 3.5. Market Restraint Analysis
    • 3.5.1. Presence of stringent rules and regulations pertaining to diagnosis
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis

  • 4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
  • 4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
  • 4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
  • 4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
    • 4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)

Chapter 5. Latent Tuberculosis Infection Detection Market: Test Estimates & Trend Analysis

  • 5.1. Global Latent Tuberculosis Infection Detection Market: Test Dashboard
  • 5.2. Global Latent Tuberculosis Infection Detection Market: Test Movement Analysis
  • 5.3. Global Latent Tuberculosis Infection Detection Market by Test, Revenue
  • 5.4. Tuberculin Skin Test (TST)
    • 5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 5.5. Interferon Gamma Released Assay (IGRA)
    • 5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)

Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis

  • 6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
  • 6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
  • 6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
  • 6.4. Household Contacts with Pulmonary TB
    • 6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 6.5. PLHIV
    • 6.5.1. PLHIV market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)

Chapter 7. Latent Tuberculosis Infection Detection Market: End Use Estimates & Trend Analysis

  • 7.1. Global Latent Tuberculosis Infection Detection Market: End Use Dashboard
  • 7.2. Global Latent Tuberculosis Infection Detection Market: End Use Movement Analysis
  • 7.3. Global Latent Tuberculosis Infection Detection Market by End Use, Revenue
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 7.5. Hospitals/Clinics
    • 7.5.1. Hospitals/Clinics market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Academic & research institutions market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)

Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.9. Netherlands
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Netherlands market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.10. Belgium
      • 8.4.10.1. Key country dynamics
      • 8.4.10.2. Regulatory framework/ reimbursement structure
      • 8.4.10.3. Competitive scenario
      • 8.4.10.4. Belgium market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.11. Finland
      • 8.4.11.1. Key country dynamics
      • 8.4.11.2. Regulatory framework/ reimbursement structure
      • 8.4.11.3. Competitive scenario
      • 8.4.11.4. Finland market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.12. Luxembourg
      • 8.4.12.1. Key country dynamics
      • 8.4.12.2. Regulatory framework/ reimbursement structure
      • 8.4.12.3. Competitive scenario
      • 8.4.12.4. Luxembourg market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.4.13. Iceland
      • 8.4.13.1. Key country dynamics
      • 8.4.13.2. Regulatory framework/ reimbursement structure
      • 8.4.13.3. Competitive scenario
      • 8.4.13.4. Iceland market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.7. Singapore
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.5.8. Bangladesh
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Bangladesh market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million, Volume in Thousand Tests)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. QIAGEN
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. BIOMERIEUX
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Oxford Immunotec
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. SD Biosensor, INC.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Wantai BioPharm
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Lionex GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Sanofi
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Serum Institute of India Pvt. Ltd
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. ARKRAY, Inc.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Par Pharmaceutical, Inc.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 North America latent tuberculosis infection detection market, by country, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 4 North America latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 5 North America latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 6 North America latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 7 North America latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 8 U.S. latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 9 U.S. latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 10 U.S. latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 11 U.S. latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 12 Canada latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 13 Canada latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 14 Canada latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 15 Canada latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 16 Mexico latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 17 Mexico latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 18 Mexico latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 19 Mexico latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 20 Europe latent tuberculosis infection detection market, by country, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 21 Europe latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 22 Europe latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 23 Europe latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 24 Europe latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 25 UK latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 26 UK latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 27 UK latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 28 UK latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 29 Germany latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 30 Germany latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 31 Germany latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 32 Germany latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 33 France latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 34 France latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 35 France latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 36 France latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 37 Italy latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 38 Italy latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 39 Italy latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 40 Italy latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 41 Spain latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 42 Spain latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 43 Spain latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 44 Spain latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 45 Denmark latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 46 Denmark latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 47 Denmark latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 48 Denmark latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 49 Sweden latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 50 Sweden latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 51 Sweden latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 52 Sweden latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 53 Norway latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 54 Norway latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 55 Norway latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 56 Norway latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 57 Netherlands latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 58 Netherlands latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 59 Netherlands latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 60 Netherlands latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 61 Belgium latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 62 Belgium latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 63 Belgium latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 64 Belgium latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 65 Sweden latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 66 Sweden latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 67 Sweden latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 68 Sweden latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 69 Finland latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 70 Finland latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 71 Finland latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 72 Finland latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 73 Denmark latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 74 Denmark latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 75 Denmark latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 76 Denmark latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 77 Luxembourg latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 78 Luxembourg latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 79 Luxembourg latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 80 Luxembourg latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 81 Iceland latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 82 Iceland latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 83 Iceland latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 84 Iceland latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 85 Rest of Europe latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 86 Rest of Europe latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 87 Rest of Europe latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 88 Rest of Europe latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 89 Asia Pacific latent tuberculosis infection detection market, by country, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 90 Asia Pacific latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 91 Asia Pacific latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 92 Asia Pacific latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 93 Asia Pacific latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 94 Japan latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 95 Japan latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 96 Japan latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 97 Japan latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 98 South Korea latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 99 South Korea latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 100 South Korea latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 101 South Korea latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 102 Australia latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 103 Australia latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 104 Australia latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 105 Australia latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 106 India latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 107 India latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 108 India latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 109 India latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 110 Singapore latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 111 Singapore latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 112 Singapore latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 113 Singapore latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 114 Bangladesh latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 115 Bangladesh latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 116 Bangladesh latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 117 Bangladesh latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 118 Rest of Asia-Pacific latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 119 Rest of Asia-Pacific latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 120 Rest of Asia-Pacific latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 121 Rest of Asia-Pacific latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 122 Latin America latent tuberculosis infection detection market, by country, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 123 Latin America latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 124 Latin America latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 125 Latin America latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 126 Latin America latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 127 Brazil latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 128 Brazil latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 129 Brazil latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 130 Brazil latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 131 Rest of the LATAM latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 132 Rest of the LATAM latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 133 Rest of the LATAM latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 134 Rest of the LATAM latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 135 MEA latent tuberculosis infection detection market, by country, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 136 MEA latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 137 MEA latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 138 MEA latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 139 MEA latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 140 Saudi Arabia latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 141 Saudi Arabia latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 142 Saudi Arabia latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 143 Saudi Arabia latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 144 Rest of MEA latent tuberculosis infection detection market, by brand, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 145 Rest of MEA latent tuberculosis infection detection market, by test, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 146 Rest of MEA latent tuberculosis infection detection market, by application, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • TABLE 147 Rest of MEA latent tuberculosis infection detection market, by end use, 2021 - 2033 (USD Million, Volume in Thousand Tests)

List of Figures

  • FIG. 1 Latent Tuberculosis Infection Detection Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment.
  • FIG. 8 Market formulation & validation
  • FIG. 9 Latent Tuberculosis Infection Detection Market snapshot
  • FIG. 10 Parent market outlook
  • FIG. 11 Related/ancillary market outlook.
  • FIG. 12 Penetration and growth prospect mapping
  • FIG. 13 Latent tuberculosis infection detection market: Brand movement analysis
  • FIG. 14 Latent tuberculosis infection detection market: Brand outlook and key takeaways
  • FIG. 15 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 16 Others estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 17 Latent tuberculosis infection detection market: Test movement analysis
  • FIG. 18 Latent tuberculosis infection detection market: Test outlook and key takeaways
  • FIG. 19 Tuberculin Skin Test (TST) market estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 20 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 21 Latent tuberculosis infection detection market: Application movement analysis
  • FIG. 22 Latent tuberculosis infection detection market: Application outlook and key takeaways
  • FIG. 23 Household contacts with pulmonary TB market estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 24 PLHIV estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 25 Others estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 26 Latent tuberculosis infection detection market: End Use movement analysis
  • FIG. 27 Latent tuberculosis infection detection market: End Use outlook and key takeaways
  • FIG. 28 Diagnostics laboratories estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 29 Hospital/Clinics market estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 30 Academic & research institutions market estimates and forecast, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 31 Global latent tuberculosis infection detection market: Regional movement analysis
  • FIG. 32 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
  • FIG. 33 Global latent tuberculosis infection detection market share and leading players
  • FIG. 34 North America, by country
  • FIG. 35 North America market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 36 U.S. key country dynamics
  • FIG. 37 U.S. market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 38 Canada key country dynamics
  • FIG. 39 Canada market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 40 Europe market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 41 UK key country dynamics
  • FIG. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 43 Germany key country dynamics
  • FIG. 44 Germany market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 45 France key country dynamics
  • FIG. 46 France market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 47 Italy key country dynamics
  • FIG. 48 Italy market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 49 Spain key country dynamics
  • FIG. 50 Spain market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 51 Denmark key country dynamics
  • FIG. 52 Denmark market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 53 Sweden key country dynamics
  • FIG. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 55 Norway key country dynamics
  • FIG. 56 Norway market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 57 Netherlands key country dynamics
  • FIG. 58 Netherlands market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 59 Belgium key country dynamics
  • FIG. 60 Belgium market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 61 Finland key country dynamics
  • FIG. 62 Finland market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 63 Luxembourg key country dynamics
  • FIG. 64 Luxembourg market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 65 Iceland key country dynamics
  • FIG. 66 Iceland market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 67 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 68 China key country dynamics
  • FIG. 69 China market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 70 Japan key country dynamics
  • FIG. 71 Japan market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 72 India key country dynamics
  • FIG. 73 India market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 74 Thailand key country dynamics
  • FIG. 75 Thailand market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 76 South Korea key country dynamics
  • FIG. 77 South Korea market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 78 Australia key country dynamics
  • FIG. 79 Australia market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 80 Singapore key country dynamics
  • FIG. 81 Singapore market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 82 Bangladesh key country dynamics
  • FIG. 83 Bangladesh market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 84 Latin America market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 85 Brazil key country dynamics
  • FIG. 86 Brazil market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 87 Mexico key country dynamics
  • FIG. 88 Mexico market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 89 Argentina key country dynamics
  • FIG. 90 Argentina market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 91 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 92 South Africa key country dynamics
  • FIG. 93 South Africa market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 94 Saudi Arabia key country dynamics
  • FIG. 95 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 96 UAE key country dynamics
  • FIG. 97 UAE market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 98 Kuwait key country dynamics
  • FIG. 99 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million, Volume in Thousand Tests)
  • FIG. 100 Market share of key market players- Latent tuberculosis infection detection market